Physician profile
Todd B Seto
NPI 1033209143
$4,041.01
in general payments reported to CMS, 2019-2025
14 companies · $799 in 2025
The $799 reported for 2025 was more than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $717 · 2020: $254 · 2021: $639 · 2022: $328 · 2023: $353 · 2024: $951 · 2025: $799.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,103.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,103.38 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $1,080.63 | 2021-2025 | |
| Abbott Laboratories | $619.14 | 2019-2025 | Triclip |
| Astrazeneca Pharmaceuticals LP | $391.18 | 2019-2024 | |
| Boston Scientific Corporation | $384.27 | 2019-2021 | |
| E.R. Squibb & Sons, L.L.C. | $364.44 | 2021-2025 | Eliquis |
| Lantheus Medical Imaging, INC. | $229.99 | 2019-2024 | Definity |
| Novo Nordisk INC | $217.79 | 2023-2024 | Wegovy, Ozempic |
| Heartflow, INC. | $165.90 | 2024 | |
| Medtronic, INC. | $162.94 | 2024 | Harmony |
| Atricure, INC. | $148.55 | 2019 | |
| Genzyme Corporation | $115.63 | 2025 | |
| Esperion Therapeutics, INC. | $99.64 | 2025 | Nexletol |
| Teleflex LLC | $38.06 | 2019 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $22.85 | 2019-2023 | Lifevest |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Todd Seto listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.